Test blood markers to understand progression to heart failure
Part of Heart & circulation clinical trials.
This study looks at blood “markers” (substances in the blood) to help explain how some people move from early heart strain to full heart failure. You may be enrolled if you have stable or worsening heart failure symptoms, or you may qualify as a healthy control for comparison.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old
- You either have stable heart failure or worsening (decompensated) heart failure symptoms, or be a healthy control
- If you have symptoms, you may have trouble breathing, fluid in the lungs, leg swelling, high neck vein pressure, or belly fluid
- Imaging (like an ultrasound/echo) must show heart failure signs such as a large heart, weak pumping, or abnormal filling pressures
- You must be able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in the blood that can predict whether the heart's pumping function improves in people with chronic heart failure. It may help doctors understand which treatments work best for each person.
This study uses simple heart tests and blood markers to sort people with chronic heart failure into different risk levels, which may help guide treatment. You may join if you have heart failure symptoms and certain test findings.
This study is looking for people who have had a heart attack or have heart failure to discover new markers in your blood that could help doctors better understand and treat heart disease. By collecting samples and health data, researchers hope to find clues that improve care for future patients.
This study looks at blood markers and body fluid measurements in people hospitalized for heart failure. It aims to better understand inflammation and fluid status, which may help guide future treatments for heart failure.
This study looks at how doctors adjust heart failure medications and uses simple blood tests (biomarkers) to see how well you respond. It aims to help fine-tune your treatment so you feel better and avoid hospital stays.
This study looks at whether certain new blood tests (biomarkers) can help doctors learn more about chronic heart failure. You might be asked for blood samples and health information, and the results could improve how heart failure is understood in the future.
Hear when a new Acute Decompensated Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.